Skip to main content

Vestal Point Capital, LP

Source: SEC Form 13F · as of Mar 2026

Vestal Point Capital, LP holds 45 biotech & pharma companies tracked by BioSniper, totaling $2.11B in value as of Mar 2026 (SEC Form 13F).

Companies held

45

Total value held

$2.11B

BioSniper AIPage evidence connected

Prepared research question

What matters most for REVOLUTION MEDICINES, INC. (RVMD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
RVMDREVOLUTION MEDICINES, INC.2,375,000$231.0M
BMRNBIOMARIN PHARMACEUTICAL INC3,575,000$202.0M
ABVXAbivax SA1,500,000$167.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.2,275,000$142.6M
ELVNEnliven Therapeutics, Inc.3,250,000$127.4M
BCAXBicara Therapeutics Inc.5,425,000$107.9M
NRIXNurix Therapeutics, Inc.6,500,000$100.8M
APGEApogee Therapeutics, Inc.1,100,000$92.6M
IMCRImmunocore Holdings plc2,766,868$83.4M
SNYSanofi1,400,000$67.5M
SRRKScholar Rock Holding Corp1,324,422$65.1M
IMTXImmatics N.V.6,175,000$60.8M
TERNTerns Pharmaceuticals, Inc.1,000,000$52.7M
NUVLNuvalent, Inc.481,715$49.4M
COGTCogent Biosciences, Inc.1,230,888$47.4M
IRONDisc Medicine, Inc.700,000$44.8M
CLDXCelldex Therapeutics, Inc.1,224,165$38.8M
KALVKalVista Pharmaceuticals, Inc.1,850,000$37.2M
SLDBSolid Biosciences Inc.5,000,000$36.0M
PTGXProtagonist Therapeutics, Inc326,159$34.4M
DNLIDenali Therapeutics Inc.1,773,326$34.0M
REGNREGENERON PHARMACEUTICALS, INC.40,000$30.9M
VKTXViking Therapeutics, Inc.914,147$29.7M
CBIOCRESCENT BIOPHARMA, INC.1,500,000$27.6M
SLNOSOLENO THERAPEUTICS INC730,000$24.4M
NKTRNEKTAR THERAPEUTICS285,000$20.5M
CYTKCYTOKINETICS INC300,000$19.8M
DMRADamora Therapeutics, Inc.600,000$15.5M
AGIOAGIOS PHARMACEUTICALS, INC.450,000$15.2M
SVRASavara Inc2,600,052$14.2M
VYGRVoyager Therapeutics, Inc.3,002,936$11.6M
TECXTectonic Therapeutic, Inc.328,000$10.1M
SRZNSurrozen Inc.338,611$9.9M
ARVNARVINAS, INC.905,465$9.6M
MPLTMapLight Therapeutics, Inc.420,000$8.5M
OKUROnKure Therapeutics, Inc.1,839,819$7.6M
OLMAOlema Pharmaceuticals, Inc.428,551$6.4M
QUREuniQure N.V.358,996$5.9M
CADLCandel Therapeutics, Inc.1,125,000$5.5M
ZBIOZenas BioPharma, Inc.200,000$3.9M
GERNGERON CORP2,540,000$3.8M
ZURAZura Bio Ltd511,000$3.0M
RGNXREGENXBIO Inc.108,525$909K
TENXTENAX THERAPEUTICS, INC.53,439$854K
ABSIAbsci Corporation232,219$697K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.